Compared with other clinical indicators (gender, age, ALT, cirrhosis, main tumor size, multinodular, BCLC stage, TNM stage, AFP, and risk score), the BCLC stage, TNM stage, and risk score showed better potential feasibility as independent prognostic factors for the RFS of HCC. This evidence concerns the gene GPT and hepatocellular carcinoma.